Myocardial infarction with normal coronary arteries complicated by ventricular septal rupture

Louis, P; Rippe, James M.; Benotti, Joseph R.; Frankel, Paul W.; VanderSalm, Thomas J.; Alpert, Joseph S.

doi:10.1016/0002-8703(84)90287-4

Cited by 11 publications

(2 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mortality rates ranged from 1% to 3% in the pre-reperfusion times, and now has decreased to 0.17%–0.31% [ 33 ]. Probably the first case of such complication in a MINOCA patient was described in 1984 [ 34 ]. In our literature search, we identified 7 such cases [ 17 , 18 , 20 , 26 , 27 , 28 , 29 ].…”

Section: Discussionmentioning

confidence: 99%

Acute Complications in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries: A Systematic Review with Special Focus on Mechanical Complications

Bil¹,

Buller²,

Gil³

et al. 2022

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Background: Recently, we have observed an increasing focus on myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) patients. MINOCA incidence is estimated to be within the range of 5-15% of all MI cases. Unfortunately, MINOCA relates to various conditions that are not rarely hard to identify, including coronary microcirculation dysfunction, epicardial coronary spasm, or plaque erosion. Our systematic review aimed to identify and appraise previous studies which characterized acute complications, with particular focus on mechanical complications, in patients with MINOCA. Methods: Applying the MeSH strategy in PubMed and Embase, two operators independently and systematically reviewed published studies on patients diagnosed with MINOCA and in whom acute complications were described. Papers published in the last 10 years (June 2012-June 2022) to reflect the introduction of the MINOCA definition as well as the current clinical practice were analyzed. The research was conducted in July 2022. Results: The search yielded 192 records. After abstract review, 79 papers were left, and after full-text analysis, we finally included 20 studies. Among 20 studies, there were: one randomized controlled trial, one prospective study, five retrospective studies, 1 case series, and 12 case reports with a total number of 337,385 patients. In the identified literature, we revealed 7 cases of intraventricular septal rupture, 3 cases of free wall rupture with pericardial effusion or cardiac tamponade, and 3 cases of bleeding complications (intracerebral or intestinal bleeding). Moreover, the ventricular arrhythmia incidence ranged from 2% to 13.8%, and the in-hospital death rate ranged from 0.9% to 6.4%. Conclusions: These findings suggest that MINOCA patients should be treated as standard MI patients with watchful monitoring, especially in the first few days.

show abstract

Section: Discussionmentioning

confidence: 99%

Acute Complications in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries: A Systematic Review with Special Focus on Mechanical Complications

Bil¹,

Buller²,

Gil³

et al. 2022

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…After meticulous research, we found only 10 published cases of MINOCA-caused VSDs. [4][5][6][7][8][9][10][11][12][13] All of them treated surgically with an overall survival rate of 60%. We did not find a case of post-MINOCA VSD treated by percutaneous approach.…”

Section: Discussionmentioning

confidence: 99%

Endovascular closure of MINOCA-caused ventricular septal defect (VSD)

et al. 2021

View full text Add to dashboard Cite

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a rare form of acute myocardial infarction and it is an even rarer cause of ventricular septal defect (VSD). We present a case of successful endovascular closure of post-MINOCA VSD with the use of an atrial septal defect (ASD) occluder. The patient improved from intra-aortic balloon pump dependent to New York Heart Association (NYHA) I in a matter of days. 18-month follow-up period is event free and symptom free.

show abstract